Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progesterone's role in neuroprotection, a review of the evidence.
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.
Treatment of Experimental Autoimmune Encephalomyelitis by Co-Delivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles.
Response to comment on "dimethyl fumarate (tecfidera): a new oral agent for multiple sclerosis".
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Established disease-modifying treatments in relapsing-remitting multiple sclerosis.
Information processing speed and attention in multiple sclerosis: Reconsidering the Attention Network Test (ANT).
Central Neuropathic Pain Syndromes.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
Feature Selection in Order to Extract Multiple Sclerosis Lesions Automatically in 3D Brain Magnetic Resonance Images Using Combination of Support Vector Machine and Genetic Algorithm.
Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.
Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
Regulation of human glia by multiple sclerosis disease modifying therapies.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Retraction notice: Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation.
A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis.
The Olig family affects central nervous system development and disease.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Pages
« first
‹ previous
…
432
433
434
435
436
437
438
439
440
…
next ›
last »